Sign in
8-K

Current Report

Niagen Bioscience, Inc. Filed Acc 0001415889-16-006977

Delisting notice · Executive or director change

  • Item 3.01 Notice of delisting or failure to meet a listing standard
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading cdxc8k_aug192016.htm…